Michael White, Ph.D. joins Samumed as Chief Scientific Officer

NEXT STORY
ERYTECH annuncia la presentazione dei poster in occasione della conferenza annuale ASCO 2020
PREV STORY
Junshi Biosciences and Merck Announce Collaboration to Explore Promising New COMBINATION Treatment for Head and Neck Cancer Patients in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to Include Exclusive U.S. Rights for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

Protalix to receive $25 million upfront, an additional up to $20 million in development ...

author_avatar
NASDAQ Market News

Half-year report and dividend declaration

author_avatar
NASDAQ Market News

Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference

author_avatar
NASDAQ Market News